When is a thrombogenic matrix not thrombogenic?
Lawler, Jack. 2016. “When Is a Thrombogenic Matrix Not Thrombogenic?”. Blood 128 (12): 1543-4.
Search
Search results
5012 results found
Thrombospondin-1-Based Antiangiogenic Therapy.
Sims, Jennifer N, and Jack Lawler. 2015. “Thrombospondin-1-Based Antiangiogenic Therapy.”. Journal of Ocular Pharmacology and Therapeutics : The Official Journal of the Association for Ocular Pharmacology and Therapeutics 31 (7): 366-70.
Counter regulation of tumor angiogenesis by vascular endothelial growth factor and thrombospondin-1.
Lawler, Jack. 2022. “Counter Regulation of Tumor Angiogenesis by Vascular Endothelial Growth Factor and Thrombospondin-1.”. Seminars in Cancer Biology 86 (Pt 2): 126-35.
Breakthrough treatments for accelerated wound healing
Freedman, Benjamin R., Charles Hwang, Simon Talbot, Brian Hibler, Simon Matoori, and David J. Mooney. 2023. “Breakthrough Treatments for Accelerated Wound Healing”. Science Advances 9 (20): eade7007.
Editorial: The mechanobiology of collagen remodeling in health and disease
Ban, Ehsan, Benjamin R. Freedman, Lucas Robert Smith, and Rebecca G. Wells. 2023. “Editorial: The Mechanobiology of Collagen Remodeling in Health and Disease”. Frontiers in Mechanical Engineering 9.
Lymph node expansion predicts magnitude of vaccine immune response
Najibi, Alexander J., Ryan S. Lane, Miguel C. Sobral, Benjamin R. Freedman, Joel Gutierrez Estupinan, Alberto Elosegui-Artola, Christina M. Tringides, et al. 2022. “Lymph Node Expansion Predicts Magnitude of Vaccine Immune Response”. BioRxiv.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Driscoll, Adam. 2020. Lorem Ipsum Dolor Sit Amet, Consectetur Adipiscing Elit, Sed Do Eiusmod Tempor Incididunt Ut Labore et Dolore Magna Aliqua.. Publihser’s Name.
The interaction of Thrombospondins with extracellular matrix proteins.
Tan, Kemin, and Jack Lawler. 2009. “The Interaction of Thrombospondins With Extracellular Matrix Proteins.”. Journal of Cell Communication and Signaling 3 (3-4): 177-87.
A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.
Ren, Bin, Keli Song, Sareh Parangi, Taiguang Jin, Min Ye, Robin Humphreys, Mark Duquette, et al. 2009. “A Double Hit to Kill Tumor and Endothelial Cells by TRAIL and Antiangiogenic 3TSR.”. Cancer Research 69 (9): 3856-65.
The effect of thrombospondin-1 on breast cancer metastasis.
Yee, Karen O, Caitlin M Connolly, Mark Duquette, Shideh Kazerounian, Raymond Washington, and Jack Lawler. 2009. “The Effect of Thrombospondin-1 on Breast Cancer Metastasis.”. Breast Cancer Research and Treatment 114 (1): 85-96.